EXINI Diagnostics

EXINI Diagnostics aims to commercialize an artificial intelligence method developed by a research group at Lund University for the automatic analysis of diagnostic images. As a certified medical device manufacturer, EXINI has developed automated analysis platforms for cardiac, brain, and bone scans. The company has consistently been innovative, having developed web-based systems in the early 2000s. EXINI's most widely distributed platform is used to calculate the automated bone scan index, which quantifies the bone tumor burden in patients with metastatic prostate cancer.